Lars Bode Selected Research

Oligosaccharides

1/2024	A Mediterranean diet plan in lactating women with obesity reduces maternal energy intake and modulates human milk composition - a feasibility study.
1/2023	Human milk variation is shaped by maternal genetics and impacts the infant gut microbiome.
1/2022	Interactions between human milk oligosaccharides, microbiota and immune factors in milk of women with and without mastitis.
1/2022	Associations between maternal obesity and offspring gut microbiome in the first year of life.
12/2021	Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis.
11/2021	Human Milk Oligosaccharides in Cord Blood Are Altered in Gestational Diabetes and Stimulate Feto-Placental Angiogenesis In Vitro.
11/2021	Oligosaccharides and Microbiota in Human Milk Are Interrelated at 3 Months Postpartum in a Cohort of Women with a High Prevalence of Gestational Impaired Glucose Tolerance.
1/2021	Human Milk Oligosaccharide Concentrations and Infant Intakes Are Associated with Maternal Overweight and Obesity and Predict Infant Growth.
1/2020	Human milk oligosaccharides and their association with late-onset neonatal sepsis in Peruvian very-low-birth-weight infants.
1/2020	Human milk oligosaccharide 2'-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Bode Research Topics

Disease

10	Infections 01/2023 - 11/2012
5	Obesity 01/2024 - 01/2020
5	Necrotizing Enterocolitis 01/2018 - 05/2012
5	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 04/2008 - 05/2005
4	Enterocolitis 12/2021 - 10/2012
4	Weight Gain 01/2020 - 01/2019
3	Birth Weight (Birth Weights) 01/2024 - 01/2020
3	Overweight 01/2022 - 01/2020
3	Malaria 01/2022 - 06/2011
2	Asthma (Bronchial Asthma) 10/2023 - 01/2022
2	COVID-19 01/2023 - 10/2022
2	Diarrhea 04/2022 - 04/2008
2	Communicable Diseases (Infectious Diseases) 01/2018 - 11/2015
2	HIV Infections (HIV Infection) 08/2014 - 08/2014
2	Hypertension (High Blood Pressure) 01/2008 - 03/2006
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 04/2006 - 03/2006
1	Maternal Obesity 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Severe Acute Respiratory Syndrome 10/2022
1	Infant Death 04/2022
1	Diseases Newborn Infant 01/2022
1	Mastitis 01/2022
1	Glucosephosphate Dehydrogenase Deficiency 01/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2021
1	Glucose Intolerance 11/2021
1	Fatty Liver 01/2021
1	Growth Disorders 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Insulin Resistance 07/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Dysbiosis 01/2020
1	Neonatal Sepsis 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Rotavirus Infections 11/2018
1	Gastroenteritis 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Milk Hypersensitivity (Milk Allergy) 01/2017
1	Virus Diseases (Viral Diseases) 08/2014
1	Bacterial Infections (Bacterial Infection) 02/2014
1	Congenital Disorders of Glycosylation 04/2009
1	Abdominal Pain (Pain, Abdominal) 04/2008
1	Univentricular Heart 04/2006
1	Crohn Disease (Crohn's Disease) 04/2006

Drug/Important Bio-Agent (IBA)

27	OligosaccharidesIBA 01/2024 - 10/2012
5	2'-fucosyllactoseIBA 04/2022 - 01/2016
5	Polysaccharides (Glycans)IBA 01/2021 - 02/2014
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2005
4	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2019
4	Blood Proteins (Serum Proteins)IBA 01/2008 - 05/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 01/2021
3	EnzymesIBA 01/2022 - 04/2009
3	lacto-N-neotetraoseIBA 11/2021 - 01/2020
3	disialyllacto-N-tetraoseIBA 01/2020 - 10/2012
3	SugarsIBA 01/2018 - 11/2012
3	Mannose (D-Mannose)IBA 04/2009 - 03/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 05/2005
2	AntigensIBA 01/2023 - 01/2020
2	Antimalarials (Antimalarial Agents)IBA 01/2022 - 01/2019
2	Volatile Fatty AcidsIBA 01/2022 - 01/2020
2	lacto-N-fucopentaose IIIBA 07/2020 - 01/2018
2	NADP (NADPH)IBA 01/2019 - 06/2011
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2008 - 05/2005
2	Heparitin Sulfate (Heparan Sulfate)IBA 03/2006 - 05/2005
1	LactoferrinIBA 01/2024
1	CytokinesIBA 01/2024
1	Hormones (Hormone)IBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	AntibodiesIBA 01/2023
1	ProteomeIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Linoleic Acid (Linoleate)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Butyric Acid (Butanoic Acid)IBA 01/2022
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	FructoseIBA 12/2020
1	Insulin (Novolin)FDA Link 07/2020
1	Glucose (Dextrose)FDA LinkGeneric 07/2020
1	LipidsIBA 01/2020
1	Protective AgentsIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	ribose-5-phosphateIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Rotavirus VaccinesIBA 11/2018
1	Virulence Factors (Pathogenicity Factors)IBA 11/2012
1	LectinsIBA 11/2012
1	GalactosamineIBA 11/2012
1	Galactose (Galactopyranose)FDA LinkGeneric 11/2012
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 09/2012
1	Sialic AcidsIBA 05/2012
1	Mannose-6-Phosphate Isomerase (Mannose 6 Phosphate Isomerase)IBA 04/2009
1	phosphomannomutaseIBA 04/2009
1	Heparin (Liquaemin)FDA LinkGeneric 04/2008
1	Proteoglycans (Proteoglycan)IBA 05/2005

Therapy/Procedure

1	Mediterranean Diet 01/2024
1	Contraindications 10/2022
1	Therapeutics 04/2008